Dataset
Thioridazine (oxide); LC-ESI-Q; MS; POS; 30 V
Chemical Information
| InChI | InChI=1S/C21H26N2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3 |
|---|---|
| SMILES | CSc(c4)cc(c(c4)1)N(CCC(C3)N(C)CCC3)c(c2)c(ccc2)S1 |
| InChI Key | KLBQZWRITKRQQV-UHFFFAOYSA-N |
| Molecular Formula | C21H26N2S2 |
| Exact Mass | 370.154 g/mol |
Data and Resources
Metadata Information
| Field | Value |
|---|---|
| DOI | |
| License URL | https://creativecommons.org/licenses/by-nc/4.0 |
| Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Waters-WA000638 |
| Version | |
| Author | |
| Maintainer | |
| Language | |
| MetadataPublished | 2016-01-19 |
| Related Molecule |
|
| Field | Value |
|---|---|
| Measurement Technique | liquid chromatography-mass spectrometry |
| Measurement Variables |
| Data-Source Molecule ID | Data-Source |
|---|---|
| 5452 | PubChem |
| PD009853 | ProbesDrugs |
| thioridazine | Atlas |
| LSM-1863 | LINCS |
| 14804036 | PubChem: Thomson Pharma |
| SCHEMBL9566 | SureChEMBL |
| PA451666 | PharmGKB |
| 50-52-2 | ACToR |
| 6096 | Brenda |
| thioridazine | DailyMed |
| CB6763367 | ChemicalBook |
| HMDB0014817 | Human Metabolome Database |
| MCULE-7796139302 | Mcule |
| CHEMBL479 | ChEMBL |
| 9566 | ChEBI |
| DB00679 | DrugBank |
| 12013415 | PubChem: Drugs of the Future |
| THIORIDAZINE | clinicaltrials |
| TP-21 | clinicaltrials |
| MELLARIL-S | clinicaltrials |
| MELLARIL | clinicaltrials |
| N3D6TG58NI | FDA SRS |
| THIORIDAZINE | rxnorm |
| DTXSID6023656 | EPA CompTox Dashboard |
| 2637 | DrugCentral |
| 50002338 | BindingDB |
| THIORIDAZINE HYDROCHLORIDE | rxnorm |
| THIORIDAZINE | DailyMed |
| J4.104A | Nikkaji |
| THIORIDAZINE HYDROCHLORIDE | clinicaltrials |
| 1933662 | eMolecules |
| 100 | Guide to Pharmacology |
| The data in this table is sourced from UniChem at EBI. | |